Upgrade to SI Premium - Free Trial

Form EFFECT Evogene Ltd.

April 6, 2026 6:01 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 3, 2026
Accession Number: 0001178913-26-001777
Submission Type: POS AM
CIK: 0001574565
Company Name: Evogene Ltd.
File Number: 333-282218

Categories

SEC Filings